- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Submit a Manuscript
- Subscription Information
- Table of Contents
The Scientific World Journal
Volume 2013 (2013), Article ID 536350, 10 pages
Involvement of MAPKs and PLC Pathways in Modulation of Pacemaking Activity by So-Cheong-Ryong-Tang in Interstitial Cells of Cajal from Murine Small Intestine
1Department of Sasang Constitutional Medicine, College of Korean Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea
2Division of Longevity and Biofunctional Medicine, Pusan National University School of Korean Medicine, Beomeori, Mulgeum-eup, Yangsan, Gyeongsangnam-do 626-870, Republic of Korea
Received 7 August 2013; Accepted 5 September 2013
Academic Editors: A. Beltsis, M. Klüppel, and C. Rizzetto
Copyright © 2013 Min Woo Hwang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Purpose. Interstitial cells of Cajal (ICCs) are the pacemaker cells that generate slow waves in the gastrointestinal (GI) tract. We have aimed to investigate the effects of Socheongryong-Tang (SCRT) in ICCs from mouse’s small intestine. Methods. The whole-cell patch-clamp configuration was used to record membrane potentials from cultured ICCs. Intracellular Ca2+ () increase was studied in cultured ICCs using fura-2 AM. Results. ICCs generated pacemaker potentials in mouse’s small intestine. SCRT produced membrane depolarization in current clamp mode. Y25130 (5-HT3 receptor antagonist) and RS39604 (5-HT4 receptor antagonist) blocked SCRT-induced membrane depolarizations, whereas SB269970 (5-HT7 receptor antagonist) did not. When GDP-β-S (1 mM) was in the pipette solution, SCRT did not induce the membrane depolarizations. analysis showed that SCRT increased . In the presence of PD98059 (p42/44 MAPK inhibitor), SCRT did not produce membrane depolarizations. In addition, SB203580 (p38 MAPK inhibitor) and JNK inhibitors blocked the depolarizations by SCRT in pacemaker potentials. Furthermore, the membrane depolarizations by SCRT were not inhibited by U-73122, an active phospholipase C (PLC) inhibitor, but by U-73343, an inactive PLC inhibitor. Conclusion. These results suggest that SCRT might affect GI motility by the modulation of pacemaker activity through MAPKs and PLC pathways in the ICCs.
Interstitial cells of Cajal (ICCs) are the pacemaking cells in the gastrointestinal (GI) muscles that generate the rhythmic oscillations in the membrane potential known as slow waves [1–3]. Slow waves propagate within ICC networks, are conducted into smooth muscle cells via gap junctions, and initiate phasic contractions by activating Ca2+ entry through L-type Ca2+ channels. The pacemaker activity in the murine small intestine is due mainly to periodic activation of nonselective cation channels (NSCC) [4, 5] or Cl− channels [6, 7]. ICCs also mediate or transduce inputs from the enteric nervous system. Therefore, in GI motility research, ICCs are the major tools to study. In these days, many new drugs are developing in the area of GI motility.
From ancient to modern history, traditional plant-based medicines have played an important role in health care. In spite of the great advances of modem scientific medicine, traditional medicine is still the primary form of healing methods readily available to the majority of the people in many countries. In fact many of today’s popular drugs have their origins in traditional medicines .
So-Cheong-Ryong-Tang (SCRT), also called Xiao-Qing-LongTtang or Sho-Seiru-To, contains eight species of medicinal plants and has been a herbal medicine used to treat diseases such as allergic rhinitis and asthma for hundreds of years in Asian countries . However, there were not many attempts to investigate the efficacy of SCRT in digestive systems.
Of the pathways related to intestinal motility, serotonin (5-hydroxytryptamine, 5-HT; a major neuromodulator) is known to play a critical role in the GI tract. Generally, 5-HT acts as a neurotransmitter in the central nervous system, but most (95%) 5-HT is found in the GI tract . Furthermore, although 5-HT is known to interact with seven different 5-HT receptor subtypes, only three of these are found in the ICCs in the murine small intestine . 5-HT can modulate pacemaker activity through 5-HT3, 4, and 7 receptors. In previous study, we suggested that poncirus trifoliate modulates pacemaker potentials through 5-HT3 and 5-HT4 receptor-mediated pathways via external Na+ and Ca2+ influx . However, the effects of SCRT and the action mechanism involved in the GI tract are not investigated.
Therefore, we undertook to investigate the effects of the SCRT on the pacemaker potentials of cultured ICCs derived from murine small intestine and to identify the receptors involved.
2. Materials and Methods
2.1. Preparation of Cells and Cell Cultures
Balb/c mice (3–7 days old) of either sex were anesthetized with ether and killed by cervical dislocation. The small intestines from 1 cm below the pyloric ring to the cecum were removed and opened along the mesenteric border. Luminal contents were removed by washing with Krebs-Ringer bicarbonate solution. The tissues were pinned to the base of a Sylgard dish and the mucosa removed by sharp dissection. Small tissue strips of the intestine muscle (consisting of both circular and longitudinal muscles) were equilibrated in Ca2+-free Hanks solution (containing in mmol/L: KCl 5.36, NaCl 125, NaOH 0.34, Na2HCO3 0.44, glucose 10, sucrose 2.9, and HEPES 11) for 30 min. Then, the cells were dispersed using an enzyme solution containing collagenase (Worthington Biochemical Co., Lakewood, NJ, USA) 1.3 mg/mL, bovine serum albumin (Sigma Chemical Co., St. Louis, MO, USA) 2 mg/mL, trypsin inhibitor (Sigma) 2 mg/mL and ATP 0.27 mg/mL. Cells were plated onto sterile glass coverslips coated with murine collagen (2.5 μg/mL, Falcon/BD, Franklin Lakes, NJ, USA) in a 35-mm culture dish and then cultured at 37°C in a 95% O2, 50 mL/L CO2 incubator in a smooth muscle growth medium (Clonetics Corp., San Diego, CA, USA) supplemented with 2% antibiotics/antimycotics (Gibco, Grand Island, NY, USA) and murine stem cell factor (SCF, 5 ng/mL, Sigma). ICCs were identified immunologically with anti-c-kit antibody (phycoerythrin-conjugated rat anti-mouse c-kit monoclonal antibody; eBioscience, San Diego, CA, USA) at a dilution of 1 : 50 for 20 min . ICCs were morphologically distinct from other cell types in the culture and thus it was possible to identify the cells by phase contrast microscopy once they had been verified with anti c-kit antibody.
2.2. Patch-Clamp Experiments
The whole-cell patch-clamp configuration was used to record membrane potentials (current clamp) from cultured ICCs. An axopatch ID (Axon Instruments, Foster, CA, USA) was used to amplify membrane currents and potentials. The command pulse was applied using an IBM-compatible personal computer and pClamp software (version 6.1; Axon Instruments). Data obtained were filtered at 5 kHz and displayed on an oscilloscope, a computer monitor, and using a pen recorder (Gould 2200, Gould, Valley View, OH, USA). Results were analyzed using pClamp and Origin (version 6.0) software. All experiments were performed at 30–32°C.
2.3. Fura-2 Loading and Measurement of Intracellular Free Calcium Ion Concentration [Ca2+]i
Cultured ICC clusters were loaded with the acetoxymethyl ester form of fura-2 (5 μmol/L; diluted from 1 mmol/L stock in dimethyl sulfoxide (DMSO)) in normal medium for 20 minutes at 37°C. The recording of was performed with a microfluorometric system consisting of an inverted fluorescence microscope (Diaphot 300; Nikon, Japan) with a dry-type fluorescence objective lens (40X; numerical aperture 0.85), a photomultiplier tube (type R 1527; Hamamatsu, Japan), and a PTI-Deltascan illuminator (Photon Technology International Inc.). Cells were superfused at a flow rate of 1.5 mL/min. Light was provided by a 75-W xenon lamp (Ushino, Japan). To control excitation frequency, a chopper wheel alternated the light path to monochromators (340 and 380 nm) with a frequency of 5 or 10 Hz. A short-pass dichroic mirror passed emission light of <570 nm onto the photomultiplier tube, and intensity was measured at 510 nm. A mechanical image mask was placed in the emission path to limit measurement to a single cell. Both data acquisition and control of light application were performed with computer software (Felix version 1.1; Photon Technology International Inc., Brunswick, NJ). Because of uncertainties in calibrating the fura-2 signals in intact cells, no attempt was made to calibrate ; instead, all results are reported as changes in the 340 nm/380 nm signal ratio.
2.4. Solutions and Drugs
The physiological salt solution used to bathe cells (Na+-Tyrode) contained (mmol/L): KCl 5, NaCl 135, CaCl2 2, glucose 10, MgCl2 1.2, and HEPES 10, adjusted to pH 7.4 with NaOH. The pipette solution contained (mmol/L): KCl 140, MgCl2 5, K2ATP 2.7, NaGTP 0.1, creatine phosphate disodium 2.5, HEPES 5, and EGTA 0.1, adjusted to pH 7.2 with KOH.
SCRT was purchased from I-WORLD Pharmaceuticals (South Korea). SCRT is composed of Rhizoma Pinelliae, Herba Ephedrae, Radix Paeoniae, Fructus Schisandrae, Herba Asari, Rhizoma Zingiberis, Ramulus Cinnamomi, and Radix Glycyrrhizae (Table 1). The dosage for adult is 10–15 g (crude materials) per day. More information about SCRT can be found in I-WORLD Pharmaceuticals Homepage (http://i-pharm.koreasme.com/). The SCRT was dissolved with distilled water at the concentration of 0.5 g (crude drug)/mL and stored in refrigerator. All other drugs were obtained from Sigma (Sigma Chemical Co., USA). Drugs were dissolved in distilled water and added to bath solution to make the desired concentrations, just prior to use. Addition of these chemicals to bath solution did not alter the pH of the solution. U-73122, U-73343, Y25130, RS39604, and SB269970 were dissolved in DMSO for 50 mmol/L stock solution and added to the bathing solution at the day of the experiment. The final concentration of DMSO in the bath solution was always <0.1%, and we confirmed that this concentration of DMSO did not affect the results that were recorded.
All data are expressed as mean ± S.E. Student’s -test for unpaired data was used to compare control and experimental groups. The value of less than 0.05 was considered statistically significant.
3.1. Effect of SCRT on Pacemaker Potentials in Cultured ICCs
To understand the relationship between SCRT and pacemaking activity in ICCs, we examined the effects of SCRT on pacemaker potentials. Recording from cultured ICC under current clamp mode () showed spontaneous pacemaker potentials. The resting membrane potential was mV, and the amplitude was mV. In the presence of SCRT (10–50 mg/mL), the membrane potentials were depolarized to 1.3 ± 0.6 mV at 10 mg/mL, 11.6 ± 1.2 mV at 30 mg/mL, and 20.3 ± 1.5 mV at 50 mg/mL (Figures 1(a)–1(e)). The summarized values and bar graph of the SCRT effects on pacemaker potentials are indicated in Figure 1(e) (). Taken together, these results show that SCRT have membrane depolarization effects on ICC.
3.2. Identification of SCRT Receptor Subtypes in Cultured ICCs
To investigate the relationship between SCRT and its receptors, we studied about the 5-HT receptors because 5-HT receptors are known to mediate the motility of GI tract and is of particular interest due to its strong association with potent prokinetic activity, especially the 5-HT receptor subtype 4 (5-HT4R) [6, 12]. In the GI tract, the stimulation of 5-HT4R in the enteric nervous system results in the release of acetylcholine, which leads to the excitation of smooth muscles in the myenteric plexus, and thus, 5-HT4R is regarded a prokinetic . Therefore, we investigated whether the prokinetic action of SCRT involves 5-HT receptors. Previous studies have shown that 5-HT interacts with seven different 5-HT receptor subtypes, but in another study only three (5-HT3R, 5-HT4R, and 5-HT7R) were found in the ICCs of the murine small intestine [6, 11, 13]. To identify the receptor subtypes of 5-HT involved in the effects of SCRT, ICCs were pretreated with various 5-HT receptor antagonists and then treated with SCRT. Y25130 (a 5-HT3 receptor antagonist), RS39604 (a 5-HT4 receptor antagonist), and SB269970 (a 5-HT7 receptor antagonist) were all pretreated at a concentration of 10 μM for 5 min, and SCRT was added. After pretreatment with Y25130, membrane depolarization by SCRT was found to be blocked (Figure 2(b)); membrane depolarization produced in the presence of Y25130 by MPF was mV (; Figure 2(e)). RS39604 also blocked SCRT-induced membrane depolarization, and the membrane depolarization produced in the presence of RS39604 by SCRT was mV (; Figures 2(c) and 2(e)). However, pretreatment with SB269970 did not block the effect of SCRT (; Figures 2(d) and 2(e)). These results show that SCRT has an effect on ICCs through 5-HT3R and 5-HT4R.
3.3. The Involvement of G Protein on SCRT-Induced Depolarizations in Pacemaker Potentials in Cultured ICCs
The effects of GDP-β-S (a nonhydrolysable guanosine 5′-diphosphate analogue that permanently inactivates G-protein binding proteins ) were examined to determine whether G-proteins are involved in the effects of SCRT on cultured ICCs. SCRT (30 mg/mL) induced membrane depolarizations on ICCs (Figure 3(a)). However, when GDP-β-S (1 mM) was in the pipette solution, SCRT (30 mg/mL) did not induce the membrane depolarizations (Figure 3(b)). The membrane depolarizations induced by SCRT were significantly affected by the presence of GDP-β-S (1 mM) in the pipette solution (, Figure 3(c)). These results show that G-protein is involved in SCRT-induced membrane depolarizations on ICCs.
3.4. Response of the Intracellular Ca2+ ([Ca2+]i) to SCRT
To investigate the effects of SCRT on oscillations, we measured spontaneous oscillations in ICCs clusters because several authors have suggested that oscillations in ICCs are primary responsible for GI pacemaker activity. Spontaneous oscillations were observed in ICCs clusters loaded with 5 μM fluo-2. Figure 4 show the changes in the 340 nm/380 nm signal ratio. In normal conditions, spontaneous oscillations were induced (Figure 4(a)). In the presence of SCRT (10 or 50 mg/mL), in ICCs was increased (Figures 4(b) and 4(c)). These results show that SCRT increase the in ICCs.
3.5. Effects of Phospholipase C Inhibitor on SCRT-Induced Depolarizations in Pacemaker Potenials in Cultured ICCs
Since the membrane depolarizations by SCRT was related to intracellular Ca2+ mobilization, we examined whether the effects on pacemaker potentials require phospholipase C (PLC) activation. To test this possibility, SCRT-induced membrane depolarizations were measured in the absence and presence of U-73122, an active PLC inhibitor . SCRT (30 mg/mL) induced membrane depolarizations on ICCs (Figure 5(a)). The pacemaker membrane depolarizations were completely abolished by application of U-73122 (5 μM), and under these conditions, SCRT-induced membrane depolarizations were not produced (; Figure 5(b)). In the presence of U-73122, the membrane depolarizations produced by SCRT were mV. The value of membrane depolarizations by SCRT was significantly different when compared with SCRT in the absence of U-73122 (, Figure 5(d)). The treatment of U-73343 (5 μM), an inactive analog of U-73122, had no influence on the pacemaker potentials, and under these conditions, SCRT-induced membrane depolarizations were not suppressed by U-73343 (Figure 5(c)). These results show that PLC pathway is involved in SCRT-induced membrane depolarizations on ICCs.
3.6. Involvements of Mitogen-Activated Protein Kinases (MAPKs) in SCRT-Induced Depolarizations in Pacemaker Potentials in Cultured ICCs
Approximately 90% of endogenous 5-hydroxytryptamine (5-HT) in the body exists in the digestive tract and 5-HT is believed to be involved in the regulation of gastrointestinal motility. Also, it has been reported that 5-HT activates MAPKs in many cell types, and thus we examined whether or not MAPKs are involved in the effects induced by SCRT by using PD98059 (a p42/44 MAPK inhibitor), SB203580 (a p38 MAPK inhibitor), or c-jun NH2-terminal kinase (JNK) II inhibitor. SCRT (30 mg/mL) induced membrane depolarizations on ICCs (Figure 6(a)). In the presence of PD98059 (10 μM), SCRT did not produce membrane depolarizations (; Figures 6(b) and 6(e)), which indicated that p42/44 plays a role in SCRT-induced membrane depolarization. In addition, SB203580 and JNK II inhibitor blocked the depolarizations by SCRT in pacemaker potentials (; Figures 6(c), 6(d) and 6(e)). These results show that the regulation of mitogen-activated protein kinases is involved in SCRT induced membrane depolarizations on ICCs.
In recent years, there has been much work done in the area of traditional medicinal plants in Korea and many good results or promising leads have been achieved . In GI motility area, ICCs are good research tools to study GI motility and therefore, many labs use ICCs.
In this study, we used ICCs and are studying to develop a new GI motility drug. Until now, SCRT was not used to treat GI motility diseases. SCRT has been widely used to treat respiratory disease such as cough and asthma in oriental countries . In this study, we found the potentials of SCRT to treat in GI motility. Because of the central role of ICCs in GI motility, loss of these cells would be extremely detrimental. Research into the biology of ICCs provides exciting new opportunities to understand the etiology of diseases that have long eluded comprehension. Discovering the molecules involved in the generation of pacemaker activity in ICCs may lead to dramatic new therapies for chronic GI diseases that result in lifelong suffering. Consequently, ICCs are involved not only in physiological GI motility but also in many bowel disorders, including inflammatory bowel disease, chronic idiopathic intestinal pseudo-obstruction, intestinal obstruction with hypertrophy, achalasia, Hirschsprung disease, juvenile pyloric stenosis, juvenile intestinal obstruction, and anorectal malformation .
5-HT plays a critical role in coordinating GI motility [18–21]. In response to intestinal stretching stimulation, 5-HT promotes peristalsis via the activation of intrinsic primary afferent neurons located in the submucous plexus [12, 22, 23]. Of the 5-HT receptors believed to influence GI motility, 5-HT3 and 5-HT4 receptors play an important role in the regulation of GI motility [12, 24–26]. Also, in guinea pig colon, 5-HT receptor was investigated . Furthermore, these receptors mediate peristaltic reflex and existed in nervous systems in the guinea pig distal colon . Liu et al.  suggested that 5-HT augments ICC pacemaker activity via 5-HT3 receptors, whereas Shahi et al.  suggested that 5-HT can modulate pacemaker activity via 5-HT3, 4, and 7 receptors. On the other hand, Wouters et al.  suggested that 5-HT2B receptors regulate the proliferation of ICCs in mouse jejunum. In Korea, poncirus trifoliate (PT) is widely used as a remedy for GI, allergic, and inflammatory diseases [29, 30]. In recent study, Kim et al.  suggested that PT exerts its prokinetic activity through a 5-HT3 and 5-HT4 receptor-mediated pathway in ICCs in mouse small intestine. In the present study, Y25130 (a 5-HT3 receptor antagonist) and RS39604 (a 5-HT4 receptor antagonist) blocked SCRT-induced membrane depolarizations, whereas SB269970 (a 5-HT7 receptor antagonist) did not. Thus, it appears that SCRT modulates pacemaker potentials through 5-HT3 and 5-HT4 receptors-mediated pathways in the ICCs of mouse small intestine (Figure 2).
In this study, ICCs generated pacemaker potentials in mouse small intestine. SCRT produced membrane depolarization in current clamp mode. Y25130 (a 5-HT3 receptor antagonist) and RS39604 (a 5-HT4 receptor antagonist) blocked MPF-induced membrane depolarizations, whereas SB269970 (a 5-HT7 receptor antagonist) did not. When GDP-β-S (1 mM) was in the pipette solution, SCRT did not induce the membrane depolarizations. Also, SCRT increased intracellular Ca2+ concentrations. To examined whether or not MAPKs are involved in the effects induced by SCRT, we used PD98059 (a p42/44 MAPK inhibitor), SB203580 (a p38 MAPK inhibitor), or c-jun NH2-terminal kinase (JNK) II inhibitor. In the presence of PD98059 (10 μM), SCRT did not produce membrane depolarizations. In addition, SB203580 and JNK II inhibitor blocked the depolarizations by SCRT in pacemaker potentials. Furthermore, the membrane depolarizations by SCRT were inhibited not by U-73122, an active phospholipase C (PLC) inhibitors but by U-73343, an inactive PLC inhibitors. These results suggest that SCRT might affect GI motility by the modulation of pacemaker activity through MAPKs and PLC pathways in the ICCs.
We think that SCRT activates PLC pathway (Figure 5) and increases intracellular Ca2+ levels (Figure 4). Intracellular Ca2+ increases induce the membrane depolarizations on ICCs and then make ICCs contractions (Figure 7). However, the exact mechanisms of membrane depolarizations on ICCs should be investigated in future.
The signaling pathways of MAPKs play important roles in the mediation of cellular responses, including visceral smooth muscle contraction. Three principal MAPKs are expressed in various tissues (p42/44, JNK, and p38 MAPK) . Furthermore, it has been demonstrated 5-HT7 receptors activate MAP kinase in hippocampal neurons  and that 5-HT induces cyclooxygenase (COX)-2 by activating MAPK in vascular smooth muscle cells , which show that 5-HT can regulate the MAPK system. In the present study, we do not know whether this SCRT has a role of 5-HT or not. However, in this study, an inhibitor of p42/44 and p38 and a JNK II inhibitor inhibited the effect of SCRT, which suggests that p38, p42/44, and JNK MAPK are involved in the modulation of pacemaker potentials by SCRT.
Taken together, our data suggest that the SCRT have an ability to regulate the pacemaker potentials in ICCs and considering the effects of this drug on the ICC, further research, including finding active compound(s) and examining their action mechanisms, is clearly needed.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
This study was supported by a Grant of the Traditional Korean Medicine R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C1886 (B120008)).
- S. M. Ward, A. J. Burns, S. Torihashi, and K. M. Sanders, “Mutation of the proto-oncogene c-kit blocks development of interstitial cells and electrical rhythmicity in murine intestine,” Journal of Physiology, vol. 480, no. 1, pp. 91–97, 1994.
- J. D. Huizinga, L. Thuneberg, M. Klüppel, J. Malysz, H. B. Mikkelsen, and A. Bernstein, “W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity,” Nature, vol. 373, no. 6512, pp. 347–349, 1995.
- K. M. Sanders, “A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract,” Gastroenterology, vol. 111, no. 2, pp. 492–515, 1996.
- S. D. Koh, J. Y. Jun, T. W. Kim, and K. M. Sanders, “A Ca2+-inhibited non-selective cation conductance contributes to pacemaker currents in mouse interstitial cell of Cajal,” Journal of Physiology, vol. 540, part 3, pp. 803–814, 2002.
- B. J. Kim, H.-H. Lim, D. K. Yang et al., “Melastatin-type transient receptor potential channel 7 is required for intestinal pacemaking activity,” Gastroenterology, vol. 129, no. 5, pp. 1504–1517, 2005.
- B. J. Kim, H. W. Kim, G. S. Lee et al., “Poncirus trifoliate fruit modulates pacemaker activity in interstitial cells of Cajal from the murine small intestine,” Journal of Ethnopharmacology, vol. 149, no. 3, pp. 668–675, 2013.
- K. Goto, S. Matsuoka, and A. Noma, “Two types of spontaneous depolarizations in the interstitial cells freshly prepared from the murine small intestine,” Journal of Physiology, vol. 559, no. 2, pp. 411–422, 2004.
- D. Bai, “Traditional Chinese medicines and new drug development,” Pure and Applied Chemistry, vol. 65, no. 6, pp. 1103–1112, 1993.
- E. Ko, S. Rho, C. Cho et al., “So-Cheong-Ryong-Tang, tradititional Korean medicine, suppresses Th2 lineage development,” Biological and Pharmaceutical Bulletin, vol. 27, no. 5, pp. 739–743, 2004.
- D.-Y. Kim and M. Camilleri, “Serotonin: a mediator of the brain-gut connection,” American Journal of Gastroenterology, vol. 95, no. 10, pp. 2704–2709, 2000.
- P. K. Shahi, S. Choi, D. C. Zuo et al., “5-hydroxytryptamine generates tonic inward currents on pacemaker activity of interstitial cells of Cajal from mouse small intestine,” Korean Journal of Physiology and Pharmacology, vol. 15, no. 3, pp. 129–135, 2011.
- M. D. Gershon and J. Tack, “The serotonin signaling system: from basic understanding to drug development for functional GI disorders,” Gastroenterology, vol. 132, no. 1, pp. 397–414, 2007.
- H.-N. Liu, S. Ohya, Y. Nishizawa et al., “Serotonin augments gut pacemaker activity via 5-HT3 receptors,” PLoS ONE, vol. 6, no. 9, Article ID e24928, 2011.
- S. M. Ward, T. Ördög, S. D. Koh et al., “Pacemaking in interstitial cells of Cajal depends upon calcium handling by endoplasmic reticulum and mitochondria,” Journal of Physiology, vol. 525, no. 2, pp. 355–361, 2000.
- T. Sakamoto, T. Unno, H. Matsuyama et al., “Characterization of muscarinic receptor-mediated cationic currents in longitudinal smooth muscle cells of mouse small intestine,” Journal of Pharmacological Sciences, vol. 100, no. 3, pp. 215–226, 2006.
- S. Jung, S. J. Cho, K. I. Moon, H. W. Kim, B. Y. Kim, and S. I. Cho, “Effects of Socheongryong-tang on immunoglobulin production in asthmatic mice,” Korean Journal of Herbology, vol. 23, no. 1, pp. 23–28, 2008.
- B. J. Kim, H.-H. Lim, D. K. Yang et al., “Melastatin-type transient receptor potential channel 7 is required for intestinal pacemaking activity,” Gastroenterology, vol. 129, no. 5, pp. 1504–1517, 2005.
- M. B. Hansen and E. Skadhauge, “Signal transduction pathways for serotonin as an intestinal secretagogue,” Comparative Biochemistry and Physiology, vol. 118, no. 2, pp. 283–290, 1997.
- J. R. Grider, A. E. Foxx-Orenstein, and J.-G. Jin, “5-hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine,” Gastroenterology, vol. 115, no. 2, pp. 370–380, 1998.
- J.-G. Jin, A. E. Foxx-Orenstein, and J. R. Grider, “Propulsion in Guinea pig colon induced by 5-hydroxytryptamine (HT) via 5-HT4 and 5-HT3 receptors,” Journal of Pharmacology and Experimental Therapeutics, vol. 288, no. 1, pp. 93–97, 1999.
- D. E. Baker, “Rationale for using serotonergic agents to treat irritable bowel syndrome,” American Journal of Health-System Pharmacy, vol. 62, no. 7, pp. 700–713, 2005.
- A. L. Kirchgessner, H. Tamir, and M. D. Gershon, “Identification and stimulation by serotonin of intrinsic sensory neurons of the submucosal plexus of the guinea pig gut: activity-induced expression of Fos immunoreactivity,” Journal of Neuroscience, vol. 12, no. 1, pp. 235–248, 1992.
- A. E. Foxx-Orenstein, J. F. Kuemmerle, and J. R. Grider, “The peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine is mediated by distinct mucosal 5-HT receptors,” Gastroenterology, vol. 108, no. 2, p. A600, 1995.
- G. J. Sanger, “5-hydroxytryptamine and the gastrointestinal tract: where next?” Trends in Pharmacological Sciences, vol. 29, no. 9, pp. 465–471, 2008.
- E. J. Dickson, D. J. Heredia, and T. K. Smith, “Critical role of 5-HT1A, 5-HT3, and 5-HT7 receptor subtypes in the initiation, generation, and propagation of the murine colonic migrating motor complex,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 299, no. 1, pp. G144–G157, 2010.
- K. B. Neal, L. J. Parry, and J. C. Bornstein, “Strain-specific genetics, anatomy and function of enteric neural serotonergic pathways in inbred mice,” Journal of Physiology, vol. 587, no. 3, pp. 567–586, 2009.
- M. Kadowaki, P. R. Wade, and M. D. Gershon, “Participation of 5-HT3, 5-HT4, and nicotinic receptors in the peristaltic reflex of guinea pig distal colon,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 271, no. 5, pp. G849–G857, 1996.
- M. M. Wouters, S. J. Gibbons, J. L. Roeder et al., “Exogenous serotonin regulates proliferation of interstitial cells of Cajal in mouse jejunum through 5-HT2B receptors,” Gastroenterology, vol. 133, no. 3, pp. 897–906, 2007.
- C. J. Lee, J. H. Lee, J. H. Seok et al., “Effects of baicalein, berberine, curcumin and hesperidin on mucin release from airway goblet cells,” Planta Medica, vol. 69, no. 6, pp. 523–526, 2003.
- J.-M. Yi, M.-S. Kim, H.-N. Koo, B.-K. Song, Y.-H. Yoo, and H.-M. Kim, “Poncirus trifoliata fruit induces apoptosis in human promyelocytic leukemia cells,” Clinica Chimica Acta, vol. 340, no. 1-2, pp. 179–185, 2004.
- G. Pearson, F. Robinson, T. Beers Gibson et al., “Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions,” Endocrine Reviews, vol. 22, no. 2, pp. 153–183, 2001.
- M. Errico, R. A. Crozier, M. R. Plummer, and D. S. Cowen, “5-HT7 receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons,” Neuroscience, vol. 102, no. 2, pp. 361–367, 2001.
- T. Machida, M. Ohta, A. Onoguchi, et al., “Hydroxytryptamine induces cyclooxygenase-2 in rat vascular smooth muscle cells: mechanisms involving Src, PKC and MAPK activation,” European Journal of Pharmacology, vol. 656, no. 1–3, pp. 19–26, 2011.